Cancer research saves lives
At Cancer Council SA, we believe that no one should lose a loved one to cancer. That’s why we are committed to finding more ways to beat cancer and improving the quality of life and survival rates for people with cancer.
Thanks to the contribution of cancer research, over the last 20 years in Australia we have seen;
- Cancer mortality rates decline by 18%.
- Cancer survival rates for some common cancers increase by as much as 36%. Today, almost 7 in 10 Australians will survive at least 5 years after a cancer diagnosis.
- An estimated 61,000 Australian lives saved by improvements in cancer prevention, screening and treatment.
Cancer Council SA’s Beat Cancer Project
Cancer Council's Beat Cancer Project has one vision – to bring us closer than ever to a future without cancer.
Since 2011, Cancer Council SA has partnered with SA Health, SAHMRI and the SA Universities to fund the Beat Cancer Project. Thanks to this collaboration and the generous donations from the community, in the past 8 years we have been able to contribute over $15 million towards ground-breaking research initiatives (including project grants, fellowships, scholarships and infrastructure and travel grants).
The research projects funded by the Beat Cancer Project cover a broad spectrum of cancer-related topics from basic science and biomedical research, through to clinical, population health and health services research. This research is being conducted in some of the most common cancers affecting South Australians including bowel, breast and skin cancers.
In 2018/19 Cancer Council SA’s Beat Cancer Project is funding 30 potentially life-saving research projects across a variety of South Australian Universities, hospitals and research centres. The projects currently funded can be found in the current funding report and through our Beat Cancer Project profile search engine.
Professor Lisa Butler (Principal Cancer Research Fellowship)
Professor Lisa Butler’s research program involves the clinical journey of patients from surgery (bedside), to laboratory research (bench), through to novel clinical trial design (bedside). Her goal is to improve treatment choices and outcomes for men with prostate cancer. By developing more sensitive, non-invasive tests to monitor tumour behaviour, new therapies can be tailored to the patients who will benefit from them the most.
Associate Professor Andrew Rowland (Mid Career Fellowship)
Professor Andrew Rowland is a leader in the field of precision dosing of anti-cancer drugs. His research aims to establish a novel, readily actionable strategy (“ADMExomoses”) to track the impact of variability in drug exposure on the effectiveness and tolerability of a class of anti-cancer drugs called kinase inhibitors (KIs). Beat Cancer’s Mid-Career Research Fellowship will enable Professor Rowland and his team to evaluate the capacity of this new strategy to efficiently generate practice-changing evidence defining the value of precision dosing for KIs.
Dr Jean Winter (Early Career Research Fellowship)
Dr Jean Winter’s research focuses on a ground-breaking new treatment strategy for breast cancer, which aims to halt tumour growth by modifying abnormal hormonal pathways in the tissue. This strategy has strong potential to increase the lifespan of breast cancer patients who develop resistance to hormone deprivation therapies.
Last reviewed May 2019.